These researchers are leading an asthma drug discovery venture aimed at treating symptoms of severe steroid-resistant asthma, with the potential use as a possible COVID-19 recovery drug.
Two approved drugs that are currently used to treat pulmonary fibrosis, help to slow but do not halt or cure the disease. There is a significant need for new drugs to treat the disease.Researchers: Katie Leach, Karen Gregory and Jiayin Diao(Monash Institute of Pharmaceutical Sciences)
Get in touch and find out which program is best for you
Sign up for our newsletter to receive updates and reminders from the TRAM team